跳至主要内容
临床试验/NL-OMON21914
NL-OMON21914招募中不适用

Effect of a new disease-specific enteral formula on metabolic control in type 2 diabetic patients.

umico Research B.V.0 个研究点目标入组 140 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
140

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Type 2 diabetic patients
  • 2. Diagnosis of type 2 diabetes according to WHO criteria for more than 6 months

排除标准

  • 1. Any gastrointestinal disease that interferes with bowel function and nutritional intake (i.e. diabetes related constipation/diarrhea secondary to neuropathy, diarrhea due to chronic inflammatory bowel disease, gastroparesis, gastrectomy)
  • 2. Concomitant intake of parenteral nutrition or other clinical enteral nutrition

研究者

发起方
umico Research B.V.

相似试验